Clinical trial
Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on…
NCT00397657 · Walter Reed Army Medical Center, U.S. Fed · Terminated
Key facts
| NCT number | NCT00397657 |
|---|---|
| Title | Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis |
| Official title | ARBITER 6: ARterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6 - HDL and LDL Treatment Strategies in Atherosclerosis (HALTS) |
| Lead sponsor | Walter Reed Army Medical Center, U.S. Fed |
| Collaborators | Abbott Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atherosclerosis |
| Intervention type | Drug |
| Interventions | extended release niacin, ezetimibe |
| Enrollment | 400 |
| Start date | Nov 1, 2006 |
| Primary completion | Aug 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Nov 9, 2006 |
| Last update posted | Jun 17, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: